Name: IOL Delivery System 2.2 mm / 2.7 mm (Foldable Intraocular Lens Injector)
Brand: Artemisine Medicines Technology Co., Ltd.

💊

Medical Device

IOL Delivery System 2.2 mm / 2.7 mm (Foldable Intraocular Lens Injector)

IOL Delivery System (MZL-2200 2.2 mm / MZL-2700 2.7 mm) — sterile single-use system for folding and implanting foldable intraocular lenses during ophthalmic surgery. Consists of a folding cartridge (polypropylene) and an injector comprising main barrel, positioner, plunger, spring and silicone pad. Ethylene-oxide sterilised, supplied sterile, single use. Registration: Liao Medical Device Registration No. 20222160090 (辽械注准20222160090). Brand: Meizilin. GMP manufactured by Artemisine Medicines Technology.

Product Name	IOL Delivery System 2.2 mm / 2.7 mm (Foldable Intraocular Lens Injector)
Dosage Form	Ophthalmic Surgical Device (Sterile, Single-Use)
Strength	MZL-2200 (2.2 mm incision) / MZL-2700 (2.7 mm incision) — 120 pcs/carton
Standards	BP / ENTERPRISE
Packing	120 pcs/carton (sterile, individually packed)
Documents	COA, COPP, DMF, CTD Dossiers
MOQ	Contact us for MOQ and current stock

Request Quotation › ← Back to Medical Device

WHO Prescribing Guidance

Indications · Administration · Dosage · Precautions

Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.

🎯Indications▾

Topical ophthalmic treatment as stated on the product label — infection, inflammation or ocular surface support (see the registered indication for your market).

💧Administration▾

Instil into the conjunctival sac using aseptic technique; discard the container 4 weeks after first opening and never share eye drops between patients.

⚖️Dosage▾

Usually 1–2 drops 3–4 times daily, or as directed by the prescriber; follow the product insert for the specific active substance.

⚠️Precautions & Warnings▾

For topical ocular use only. Stop and seek advice if pain, worsening vision or persistent redness develops; avoid contact lenses during treatment.

Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.